Organon To Buy Psoriasis Treatment Biz For Up To $1.2B
By Jade Martinez-Pogue · September 18, 2024, 1:47 PM EDT
Women's healthcare-focused company Organon, advised by Covington & Burling LLP, on Wednesday announced it will purchase Freshfields Bruckhaus Deringer LLP-led Dermavant, a subsidiary of Roivant that develops and commercializes therapies in...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login